Mice Model Market Worth 1,370.

5 Million USD By 2023

The global Mice Model (Models, services and care products) market is expected to
grow at a CAGR of 7.2% during the projected period to reach USD 1,370.54 million by
2023 from USD 968.36 million in 2018. The growth of this market is mainly attributed
to the continuing modification in mice model for cancers, immune diseases, and rare
diseases; increasing devouring of personalized medicine propelling the demand for
humanized mice model; rising grants and investments for biological research; rising
pharmaceutical R&D activities; and increasing focus of International Mouse
Phenotyping Consortium (IMPC) and International Knockout Mouse Consortium
(IKMC) on the development of embryonic stem cells as well as knockout and mutant
mice.

Browse in-depth Report on:

https://www.meticulousresearch.com/product/mice-model-market/

The evolution of alternative techniques to animal testing, improvement in zebrafish

model development, and growing need for improved mice models are the major
challenges in the global mice model market. In addition, evolution of CRISPR-Cas9
gene editing technology in the field of biomedical research, increasing demand for
humanized mice model, and rising monoclonal antibody production provides
significant opportunities for the various stakeholders in the global mice model market.
However, factors such as increasing use of rat models, increased advantages from
cryopreservation, and government regulations and laws for ethical use of animals in
research hampers the growth of mice model market to some extent.

MARKET DYNAMICS:
The continuous modification in mice model allows researchers to find out the
appropriate solution for complex biology during the treatment of various chronic
diseases. The mouse models are playing important role in the development of immune
therapies. For instance, the recent research led by University of California developed
a new class of drugs known as immune checkpoint inhibitors. These drugs have been
used for the treatment of a growing number of patients with cancer, including some
who had run out of treatment options.

For detail study insights , download key sample:

https://www.meticulousresearch.com/download-sample-report/cp_id=4151
Cancer remains to be the second leading cause of death in the U.S., it was estimated
that in 2017, 30% of all new cancer cases among women were breast cancer. In 2018,
the federal budget prioritizes Medical Research and Cancer Prevention, which
includes a $3 billion increase for medical research at the National Institutes of Health
(NIH) a $275 million increase for the National Cancer Institute (NCI); a $10 million
increase for cancer prevention programs at the Centers for Disease Control and
Prevention (CDC).

TRENDS
The rapidly growing ageing population and advances in cancer therapy have sparked
tremendous interest in the improvement of mice models. For many years, cancer
biologists have taken two distinct approaches to modeling cancer. One is to grow
immortalized human cancer cells, known as cancer cell lines in a lab dish, but they
don’t really reproduce the complex in vivo environment of a tumor.

Contact Info:
Meticulous Market Research Pvt. Ltd.
Khushal
Email: sales@meticulousresearch.com
Contact Sales- +91-744-7780008

According to the American Cancer Society, about 1,688,780 new cancer cases were
diagnosed in 2017 in the U.S. About 600,920 Americans were expected to die of
cancer in 2017, which translate to about 1,650 people per day. Cancer is the second
most common cause of death in the U.S., exceeded only by heart diseases, and
accounts for nearly 1 of every 4 deaths. In addition, growing geriatric population in the
U.S. is the major factor for growing cancer incidence across the U.S. For instance,
87% of all the cancers in the U.S. are diagnosed in people 50 years of age and older.